A DIRECT COMPARISON OF TWO OBJECTIVE METHODS FOR DETECTION OF NON-ADHERENCE IN PATIENTS WITH UNCONTROLLED HYPERTENSION

Ida Regine Bilet Hamsund,Bård Waldum - Grevbo,Aud H⊘ieggen,Amin Amro,Nina Olsvold,Lene Vernås Halvorsen

DOI: https://doi.org/10.1097/01.hjh.0001019856.66225.b7

IF: 4.9

2024-05-01

Journal of Hypertension

Abstract:Objective: Uncontrolled hypertension remains a major health challenge leading to premature death and cardiovascular morbidity. We have previously reported a prevalence of non–adherence to antihypertensive drugs from 8-30% of patients studied by either directly observed therapy (DOT) or serum drug concentrations (S- conc.) of antihypertensive medication. We aimed to investigate the prevalence of non–adherence in patients with uncontrolled hypertension consecutively referred to our outpatient clinic and to compare results from DOT and s-conc. in the same patient. Design and method: Nine, of planned 20 patients referred to 24-hour ambulatory blood pressure measurement (ABPM) were included in these preliminary results. Inclusion criteria was uncontrolled blood pressure (office SBP >140 mmHg) despite the use of three antihypertensive drugs. ABPM were measured at baseline and repeated after 3-4 weeks, the second time following DOT. S-conc. of antihypertensive drugs were measured by ultra-high-performance-liquid-chromatography tandem mass spectrometry at baseline and 24 hours after DOT. Patients with s-conc. of at least one drug below a predefined reference level were considered to be non–adherent. At the final visit patients evaluated how they experienced the DOT and s-conc. measurements by a visual analogue scale (VAS score) from 0 –10. Results: Of nine patients (age 36-79), five adherent (54,5%) and four (45,5%) non-adherent were detected by s-conc. Baseline mean for Ambulatory systolic blood pressure (ASBP) at visit one was 138±19 mmHg and mean ASBP after DOT 134±14 mmHg (p = 0,33). ASBP fell by 12±9 mmHg after DOT in the non-adherent group compared to a rise by 2±10 mmHg in the adherent group (p=0,079). Five patients completed the VAS evaluation, none of them experienced DOT or measuring s-conc. unpleasant. Conclusions: The difference in ASBP after DOT in the two groups showed a clear trend. Preliminary data in patients with uncontrolled hypertension show that both DOT and measurement of serum concentrations of antihypertensive drugs are reliable methods for detecting non–adherence and are well accepted by the patients. These methods may be used complementary in the outpatient clinic.

peripheral vascular disease